Menu

Global Antibody Production Market Size, Share, Trends, Industry Statistics Report, By Type (Monoclonal, Polyclonal); Device (Bioreactors, Chromatography, Consumables); By End User (Biopharmaceutical/Pharmaceutical Companies, Research & Academic Institutes, Diagnostic Laboratories); Regional Analysis (North America - U.S, Canada, Other) (Asia-Pacific - India, Japan, China, South Korea, Japan, Australia, and Other) (Europe - U.K., Germany, Netherlands, Lithuania, Austria, Belgium, Poland, Sweden, Spain, France, Russia and Other) (Middle East - Saudi Arabia, UAE and Africa - South Africa, Zimbabwe and RoW) - Global Industry Insights, Trends and Forecast, 2019-2025

Report Format : PDF
Published Date : Jan-2019
Pages : 185
Report ID : VSR002071

Global Antibody Production Market Size is estimated to expand rapidly in the coming years, at a CAGR of 12 % from 2018 to 2025. In 2017, the global market valuation was USD 0.8 billion, and it is anticipated to be greater than USD xx.xx billion by 2025.

Introduction

An antibody is otherwise called immunoglobulin, which is a Y-formed protein that is created by a safe framework to keep trespassers from hurting the body. In the event that it is discovered, at that point the safe framework starts delivering a counteracting agent, which is an in vivo process; anyway, the immune response can be made invitro. The counteracting agent generation market involves items that are required during the various phases of bioprocessing of antibodies, for example, upstream preparing, downstream handling and filtration. Antibodies are discharged by B cells of the versatile resistant framework, for the most part by separated B cells called plasma cells. Antibodies can happen in two physical structures, a dissolvable structure that is emitted from the cell to be free in the blood plasma, and a layer bound structure that is appended to the outside of a B cell and is alluded to as the B-cell receptor (BCR). Antibodies are glycoproteins having a place with the immunoglobulin superfamily. They comprise the majority of the gamma globulin part of the blood proteins.

Global Market Growth Opportunities (Revenue, Growth) By 2018-2025

Global Antibody Production Market Size, Share, Trends, Industry Statistics Report

This global market study report analysis offers in-depth insights, revenue details, and other vital information regarding the global antibody production market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2025. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global antibody production market report has been segmented on the basis of type, application, and region. It includes the estimation of the market size, in terms of value, with respect to 4 main geographies, namely, North America, Europe, APAC, and RoW.

Market Dynamics

Worldwide Antibody Production Market is relied upon to develop at a CAGR of over 12% in the forecast period. Expanding interest for restorative antibodies including monoclonal and polyclonal antibodies is a central point that drives the development of the market during the gauge period. Antibodies are the overwhelming biopharmaceuticals that explicitly focus on unusual cells. In this manner, numerous pharmaceuticals and biotechnology organizations have started to concentrate on the improvement of cutting edge antibodies for the treatment of incessant infections, for example, malignancy, rheumatic coronary illness, and joint pain. The development is combined with an expanding requirement for protein curatives and rising boundless nearness of irresistible infection. Different variables impelling the development of the Global Antibody Production Market are the patent end of fruitful monoclonal antibodies, raised R&D dispensing of biotechnology and pharmaceutical organizations, rising acknowledgment of focused immunotherapy and helpful antibodies by overseeing specialists. The expanding focal point of biopharmaceutical and biotechnology organizations to deliver immune response therapeutics is a central point driving the development. These therapeutics are exceptionally powerful in the treatment of rheumatoid joint pain, malignancy, and other incessant sicknesses. In this manner, the generation of remedial antibodies is expanding, which is required to drive the development of the Global Antibody Production Market during the gauge time frame.

Segment Analysis

The worldwide antibody production market is divided by procedure, end client, and locale. In light of procedure, the market is sorted into upstream preparing, downstream handling, and filtration. The upstream preparing portion is additionally isolated into bioreactors and consumables.

The bioreactors section is subdivided into enormous scale bioreactors and single-use bioreactors, while consumables fragment is sub-segmented into media and supports and reagents. The market by filtration is grouped into filtration frameworks and filtration consumables and embellishments. By end client, the market is grouped into pharmaceutical and biotechnology organizations, symptomatic labs, and research foundations.

Regional Analysis

Geographically, it is analyzed across North America, Europe, Asia Pacific, and LAMEA. North America had the highest market share in 2017. The Global Antibody Production Market is driven by the factor including the presence of many large biotechnology and biopharmaceutical firms in this region. In addition, the highly developed healthcare & research infrastructure and increased focus on drug discovery in North America have fuelled the regional Global Antibody Production Market growth. The Asia Pacific is expected to exhibit the highest growth during the forecast period, owing to untapped opportunities in this region. There are many biopharmaceutical and clinical research organizations companies, which are targeting Asian countries, such as China & India for drug discovery and development. The presence of less stringent regulations for antibodies development & production, vast genome pool, and developing healthcare infrastructure in this region are some of the major factors contributing to the growth of the sector in this region.

Global Antibody Production Market Size, Share Analysis by Region 2018

Global Antibody Production Market Size, Share, Trends, Industry Statistics Report

Global Antibody Production Market Study Objective

1. To forecast the market size of antibody production market, along with describing and defining the market, in terms of volume and revenue as well as market opportunities for stakeholders, in order to provide a competitive landscape for global market players.

2. Market analysis and forecast of antibody production market on the basis of region, substrate, and application or end-use industry. To profile major market players, and to analyze their market shares and essential competencies comprehensively.

3. To analyze and elaborate significant factors that will have a major impact on the growth of antibody production market, such as drivers, restraints, challenges, and opportunities.

4. The regional analysis of antibody production market, to induce market size of five global major regions, which include, Europe, North America, South America, Middle East & Africa, and the Asia Pacific.

5. Strategic analysis of micro-markets, in terms of individual prospects, opportunities, growth trends and their involvement in the overall market.

6. To provide a detailed analysis of competitive and strategic developments in the antibody production market like a new product launch, partnership & agreement, investment & expansion, and company merger & acquisitions.

Key Players Landscape

The companies profiled in the report are GeneTex, Inc., Thermo Fisher Scientific, Inc., Eli Lilly and Company, Merck KGaA, Pall Corporation, Sigma-Aldrich Corporation, Eppendorf AG, Cellab GmbH, Abcam PLC, and FiberCell Systems Inc. Such manufacturers plan to supply customized goods to increase consumer base and market share. They also focus on increasing geographical reach in order to gain maximum application penetration, especially in developing countries. It is likely to be a key factor in success for companies to set up R&D centers, together with strategic partnerships with investment companies, to introduce innovative technologies.

Global Antibody Production Market Study Report Offer You!

The global antibody production market study report gives an idea about market size, share, stock, equity, investment and total price analysis. Also, the report provides comprehensively industry insights with all major factors such as market credit, allocation, demand, distribution, market scope, key players, end-user & applications, provisions, livestock, commodities and industry economics analysis, future growth & forecast. The global market report includes all depth data like pre-market emphasis, market survey, market investment, industry advice, portfolio, finance, access, trade, market exploration, industry review and market predication & projection to develop effective strategies for optimizing their market position.

Enquiry for Table of Content

Global Antibody Production Market Size, Share, Trends, Industry Statistics Report, By Type (Monoclonal, Polyclonal); Device (Bioreactors, Chromatography, Consumables); By End User (Biopharmaceutical/Pharmaceutical Companies, Research & Academic Institutes, Diagnostic Laboratories); Regional Analysis (North America - U.S, Canada, Other) (Asia-Pacific - India, Japan, China, South Korea, Japan, Australia, and Other) (Europe - U.K., Germany, Netherlands, Lithuania, Austria, Belgium, Poland, Sweden, Spain, France, Russia and Other) (Middle East - Saudi Arabia, UAE and Africa - South Africa, Zimbabwe and RoW) - Global Industry Insights, Trends and Forecast, 2019-2025

Enquiry for Methodology

Global Antibody Production Market Size, Share, Trends, Industry Statistics Report, By Type (Monoclonal, Polyclonal); Device (Bioreactors, Chromatography, Consumables); By End User (Biopharmaceutical/Pharmaceutical Companies, Research & Academic Institutes, Diagnostic Laboratories); Regional Analysis (North America - U.S, Canada, Other) (Asia-Pacific - India, Japan, China, South Korea, Japan, Australia, and Other) (Europe - U.K., Germany, Netherlands, Lithuania, Austria, Belgium, Poland, Sweden, Spain, France, Russia and Other) (Middle East - Saudi Arabia, UAE and Africa - South Africa, Zimbabwe and RoW) - Global Industry Insights, Trends and Forecast, 2019-2025

Single User: $4,999
Multi User: $6,999
Enterprice Licence: $8,999

Get 15% Discount

Why Choose Veracious Statistics Research ?

Save Your Time

Cost-Effective Services

Wide Range of Reports

World Class Market Research

100% Customer Satisfaction

24/7 Customer care Support

Any more questions?

Get in touch with us quickly and easily. We are happy to help!

Contact us

Sales Shaulova

Global Operations Manager +1-937-947-0908 Mon - Fri - 24/7/

Let's Talk Online